The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback